Saving this for reference. Top-tier content.
Slightly tangential to Cash-pay GLP-1 pricing but sarah_TO reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
+1 to sarah_TO. Especially the point about "A few questions about your Cash-pay GLP-..." — I have seen the same in my own experience with Cash-pay GLP-1 pricing.
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesDr.PathRoch — that is really helpful context on Cash-pay GLP-1 pricing. Follow-up question: how long did you wait before increasing your dose?
I am in a similar situation (week 4) and trying to set realistic expectations.
To answer jim_asheville's question specifically:
From a clinical standpoint, Cash-pay GLP-1 pricing is a reasonable concern that deserves a thorough answer.
The short answer: the evidence supports this approach for most patients.
The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.